Introduction
============

Dental agenesis is one of the most common congenital anomaly of human dentition, with a prevalence (excluding third molars) ranging from 2.6 to 11.3% ([@b1-ijmm-38-05-1338]). Relative to the number of missing teeth, dental agenesis can be classified as hypodontia (when 1 to 5 teeth are missing), oligodontia (when 6 or more teeth are missing), or anodontia (when the complete failure of dentition development occurs). The most frequently missing teeth are the mandibular second premolars, followed by the maxillary lateral incisors and maxillary second premolars ([@b2-ijmm-38-05-1338]). It is generally accepted that both genetic and environmental factors play a significant role in the pathogenesis of this disease ([@b3-ijmm-38-05-1338]). Tooth agenesis may occur either in association with genetic syndromes characterized by other inherited anomalies as an isolated non-syndromic familial trait, or as sporadic cases. Familial tooth agenesis is characterized by moderate genetic heterogeneity and has been reported to have an autosomal-dominant, autosomal-recessive or X-linked mode of inheritance ([@b4-ijmm-38-05-1338],[@b5-ijmm-38-05-1338]).

Tooth development requires a complex network of molecular interactions in which the activation of the nuclear factor-κB (NF-κB) and WNT signaling pathways indeed play a central role. The transcription factor, NF-κB, controls several cellular functions and it is activated by members of the tumor necrosis factor receptor (TNFR) superfamily, including EDA receptor (EDAR). Ectodysplasin (EDA) is a member of the tumor necrosis factor (TNF)-related ligand family and binds to its membrane receptor, EDAR, that in turn binds to its adaptor, EDAR-associated death domain (EDARADD). The EDA-EDAR-EDARADD complex activates the NEMO-IKK signaling cascade, allowing the nuclear translocation of NF-κB and thus the transcriptional control of genes that are crucial for tooth development ([@b6-ijmm-38-05-1338]).

WNT signaling molecules play important roles in the differentiation of tissues and organs during embryonic development. The secretion of WNTs, including WNT4, WNT6, and WNT10 from the dental epithelium is essential for tooth development. WNT10A is expressed in the dental epithelium and mesenchyme. Similar to other WNT proteins, it binds to the Frizzled (Fz) transmembrane receptors and to lipoprotein receptor-related protein 5/6 (LRP5/6) coreceptors, leading to the activation of the β-catenin pathway ([@b7-ijmm-38-05-1338]).

One of the direct downstream targets of WNT/β-catenin signaling during craniofacial development is Msh homeobox 1 (MSX1). MSX1 is a homeobox gene encoding a transcription factor that regulates the expression of bone morphogenetic protein 4 (BMP4), a member of the transforming growth factor-β (TGF-β) superfamily, during the bud and cap stages of the tooth development. In these phases, MSX1 interacts with paired box 9 (PAX9) both at the gene and protein levels, with MSX1 and PAX9 being intimately involved in the genetic networks regulating tooth development ([@b8-ijmm-38-05-1338]). PAX9 is a transcriptional factor that plays a key role during embryogenesis by modifying the transcriptional activity of downstream genes. In particular, by physically associating with MSX1, it enhances both MSX1 and BMP4 gene expression during tooth development ([@b9-ijmm-38-05-1338],[@b10-ijmm-38-05-1338]). On the other hand, Axin 2 (AXIN2), also known as conductin/axil, is an inhibitor of the WNT signaling pathway ([@b11-ijmm-38-05-1338]).

Previously, dominant loss-of-function mutations in MSX1, PAX9 and AXIN2 have been described in familial forms of non-syndromic tooth agenesis ([@b12-ijmm-38-05-1338]). Recently, the WNT10A variant has been described in up to 50% of analyzed patients with dental agenesis and also in various ectodermal dysplasia syndromes ([@b13-ijmm-38-05-1338],[@b14-ijmm-38-05-1338]). Mutations in EDA, EDAR and EDARADD have also been shown to be associated with both isolated tooth agenesis and syndromic tooth agenesis, such as X-linked hypohidrotic ectodermal dysplasia (XLHED), a rare anomaly involving sparse hair, dental abnormalities, skin lesions and hypoplasia of sweat glands ([@b15-ijmm-38-05-1338]).

The initial aim of this study was to evaluate the MSX1 and PAX9 mutation rate in a cohort of patients and subsequently to identify the causative gene mutations associated with auto-somal tooth agenesis in some families by employing whole exome sequencing (WES).

Subjects and methods
====================

Study subjects
--------------

The probands (n=9; [Fig. 1](#f1-ijmm-38-05-1338){ref-type="fig"}) were patients who were 10 to 20 years of age enrolled at the Dental Clinic of the University of Brescia, Italy, from 2008 to 2014, with a confirmed diagnosis of dental agenesis, but without systemic or syndromic diseases. When available, parents and siblings either affected or not, were also enrolled in the study. All individuals enrolled were informed of the purpose of this study and signed an informed consent. All clinical and genetic studies were approved by the Ethics Committee of the Spedali Civili of Brescia (AOBS-GENI-2011; NP 1119) and were conducted according to the principles expressed in the Declaration of Helsinki. In addition to panoramic radiography, a clinical examination was conducted on a dental chair, under artificial light, with a probe and a dental mirror by two trained dentists.

Mutation analysis by Sanger sequencing
--------------------------------------

Genomic DNA was isolated from the peripheral blood of affected individuals and available affected/non-affected relatives using the Purgene Blood Core kit (Qiagen, Valencia, CA, USA) following the instructions of the manufacturer. DNA from peripheral blood of a control (CTRL) unaffected subject was also isolated. The PAX9 and MSX1 coding sequences were amplified by PCR using the primers and the thermal cycler protocols previously described ([@b16-ijmm-38-05-1338]--[@b18-ijmm-38-05-1338]). The amplified products were sequenced using the BigDye Terminator v3.1 Cycle Sequencing kit and analyzed using the ABI PRISM 310xl Genetic Analyzer (both from Applied Biosystems, Foster City, CA, USA). The results were compared with the reference sequences for each (MSX1, NM_002448.3; PAX9, NM_006194.3).

The exons and approximately 30 bp of the flanking introns of the WNT10A and EDARADD genes were amplified with the primers previously described ([@b19-ijmm-38-05-1338]). The results were compared with the reference sequences for each gene (WNT10A, NM_025216.2; EDARADD, NM_080738.3).

Whole exome sequencing (WES)
----------------------------

WES was carried out in selected affected individuals and their relatives. In total, 12 cases were examined by WES and the details of the subjects analyzed are reported in [Fig. 1](#f1-ijmm-38-05-1338){ref-type="fig"}. The exomes of the probands of families 1, 5, 7 and 8 were sequenced at Personal Genomics (University of Verona, Italy) using the TruSeq Exome Enrichment kit (Illumina, San Diego, CA, USA) for whole exome capture. The members of family 5 (I-1, I-2, II-2), family 8 (I-1, I-2) and family 9 (I-2, II-2, II-3) had their exomes sequenced at Erasmus MC, University Medical Center Rotterdam using the Nimblegen SeqCap EZ Exome version 2.0 exome capture kit. In both protocols, paired-end libraries were sequenced on the Illumina HiSeq instrument. Sequencing reads were aligned to the human genome reference sequence (hg19) using BWA-mem ([@b20-ijmm-38-05-1338]) and then processed according to GATK 3.4--46 best practices ([@b21-ijmm-38-05-1338]) for variant discovery. Briefly, aligned reads were processed for duplicate removal using Picard and the base quality score recalibration was performed using GATK. The processed BAM files of single probands or the proband and relatives were then analyzed using GATK HaplotypeCaller for the identification of both single nucleotide polymorphisms (SNPs) and indel variants. Reported variants in VCF file format were then filtered removing those with a read depth \<6 and a genotype quality (GQ) \<20. Subsequently, the filtered variants were annotated using ANNOVAR ([@b22-ijmm-38-05-1338]) and selected according to the following criteria: i) exonic, non-synonymous variants; ii) reported allele frequency in 1000G phase 3 data and ExAc 0.3\<1%; and iii) not located in segmental duplicated region. These variants were searched for mutations in known genes related to dental agenesis. Where no mutations emerged, the data of the family pedigree were analyzed to select variants segregating according to the disease hereditary model. These variants were further annotated with known phenotypes from the ClinVar database ([@b23-ijmm-38-05-1338]) and the RVIS score ([@b24-ijmm-38-05-1338]) that provides an estimate of the tolerance to functional variations for each gene. Candidate genes variants were then prioritized based on PolyPhen2 ([@b25-ijmm-38-05-1338]) and FATHMM ([@b26-ijmm-38-05-1338]) deleteriousness predictions and the RVIS score of the associated gene.

Results
=======

Study subjects
--------------

A total of 9 females and 7 males ranging in age from 8 to 48 years affected by tooth agenesis from 9 different families were enrolled in this study ([Fig. 1](#f1-ijmm-38-05-1338){ref-type="fig"}). In particular, 5 individuals were affected by oligodontia (number of missing teeth ≥6) and 11 individuals by hypodontia (number of missing teeth ≤5). The most common missing teeth were the mandibular second premolars (35 in 10/16 affected; 45 in 9/16 affected), maxillary lateral incisors (12 in 5/16 affected; 22 in 5/16 affected) and maxillary second premolars (15 in 4/16 affected; 25 in 4/16 affected) ([Tables I](#tI-ijmm-38-05-1338){ref-type="table"} and [II](#tII-ijmm-38-05-1338){ref-type="table"}).

Mutation analysis of PAX9 and MSX1 genes
----------------------------------------

To identify causative mutations in subjects with tooth agenesis, we performed direct sequencing of the PAX9 and MSX1 genes in 9 affected subjects ([Fig. 1](#f1-ijmm-38-05-1338){ref-type="fig"}, individuals marked with an asterisk). Ultimately, the mutation analysis of the PAX9 and MSX1 genes did not highlight the presence of any causative mutation in the 9 affected individuals.

WES
---

Since the genetic heterogeneity of tooth agenesis has become apparent and has expanded since our first screening, to include 17 different genes, we decided to apply WES to identify novel and/or previously described causative mutations, as well as new candidate genes. Overall, we performed WES on 12 subjects from 5 distinct families ([Fig. 1](#f1-ijmm-38-05-1338){ref-type="fig"}, individuals marked with a filled square; [Table II](#tII-ijmm-38-05-1338){ref-type="table"}, individuals highlighted in grey) with a mean coverage across target region of 75X-171X and 22,482-37,874 variants identified per subject in exonic regions ([Table III](#tIII-ijmm-38-05-1338){ref-type="table"}).

For 2 families, it was possible to identify known causative mutations, thus providing a molecular diagnosis. The already described p.F228I mutation (rs121908120) in the homozygous state in the WNT10A gene was detected in the proband of family 7 and confirmed by Sanger sequencing; her unaffected mother displayed the same variant in the heterozygous state ([Fig. 2](#f2-ijmm-38-05-1338){ref-type="fig"}). The same mutation was also detected in both the affected siblings from family 1 ([Fig. 3](#f3-ijmm-38-05-1338){ref-type="fig"}). Moreover, the proband (II-1, oligodontia) and her brother (II-2, more severe phenotype) also carried a p.S103F mutation (rs114632254) in the EDARADD gene in the heterozygous state ([Fig. 3](#f3-ijmm-38-05-1338){ref-type="fig"}). Both mutations were confirmed by Sanger sequencing. In 3 other families, our analysis led to the identification of novel candidate variants in genes with a potential role in tooth agenesis.

In family 5, an autosomal recessive form of inheritance seemed to be most probable ([Fig. 1](#f1-ijmm-38-05-1338){ref-type="fig"}). In both the affected siblings, we found compound heterozygous mutations in the Mucin 16 (MUC16) and Titin (TTN) genes and a homozygous genetic variation c.-387delC/G in the 5′UTR portion of the paired-like homeodomain 2 (PITX2) gene. Furthermore, in the proband (II-1) and in her brother, we detected an SNP (c. T455C:p.V152A; rs17563) in the homozygous state in the BMP4 gene previously associated with tooth agenesis ([Table IV](#tIV-ijmm-38-05-1338){ref-type="table"}).

Family 8 was also likely to present a recessive form of inheritance ([Fig. 1](#f1-ijmm-38-05-1338){ref-type="fig"}). The proband displayed homozygous non-synonymous single nucleotide variants (SNVs) in the aryl-sulfatase family member H (ARSH), proline rich 32 (PRR32) and apurinic/apyrimidinic endodeoxyribonuclease 2 (APEX2) genes, a nucleotide change in homozygosis in transglutaminase 4 (TGM4) resulting in a premature stop codon and a 40 bp frameshift insertion in homozygosis in the placenta specific 4 (PLAC4) gene. Putative *de novo* heterozygous genetic variants were identified in 14 genes, 4 of whom displayed compound heterozygous gene alterations. Furthermore, the homozygous genetic variant in the 5′UTR portion of the PITX2 gene identified in family 6 was also present in the proband of family 8 ([Table V](#tV-ijmm-38-05-1338){ref-type="table"}).

Finally, an autosomal recessive form of inheritance was likely also for family 9. The father could not be included in the study and the analysis was conducted on the twin proband (II-2) and on his unaffected mother and brother ([Fig. 1](#f1-ijmm-38-05-1338){ref-type="fig"}). The proband evidenced a non-synonymous SNP in the heterozygous state in the ankyrin repeat and EF-hand domain containing 1 (ANKEF1), COMM domain-containing protein 7 (COMMD7), DDHD domain containing 1 (DDHD1), early B-cell factor 2 (EBF2), envoplakin (EVPL), SPT6 homolog, histone chaperone (SUPT6H) genes and a compound heterozygous mutation in the succinate-CoA ligase GDP-forming beta subunit (SUCLG2) gene ([Table VI](#tVI-ijmm-38-05-1338){ref-type="table"}).

Discussion
==========

The main objective of this study was to identify the causative genetic defects in subjects affected by non-syndromic tooth agenesis. We began with Sanger sequencing of the PAX9 and MSX1 genes, since they were considered in the literature the most probable candidate genes ([@b27-ijmm-38-05-1338]). This analysis performed on 9 individuals affected by agenesis did not evidence any mutation, thus suggesting that other genes may be involved in tooth agenesis, in agreement with other published data ([@b28-ijmm-38-05-1338]) Mutations in the WNT10A gene emerged as frequently involved ([@b13-ijmm-38-05-1338],[@b14-ijmm-38-05-1338]) We decided to use the WES technology to identify causative mutations. We identified pathogenic mutations in the proband of family 1 and the same alterations in her brother. The subjects displayed a known homozygous disease mutation in the WNT10A gene (p.F228I, rs121908120) and a heterozygous mutation in the EDARADD gene (p.S103F, rs114632254). The frequent p.F228I aminoacid substitution is associated with the autosomal dominant or autosomal recessive form of isolated hypodontia and ectodermal dysplasia ([@b29-ijmm-38-05-1338]). The EDARADD mutation p.S103F was previously predicted to be harmful for protein function by bioinformatics analysis ([@b19-ijmm-38-05-1338]). This particular combination of genetic variants involving two genes related to teeth development has never been previously described, at least to the best of our knowledge. Both the affected individuals had oligodontia, but individual II-1 had 17 missing teeth and subject II-2 had 6 missing teeth. By WES, we identified the pathogenic mutation in the proband of family 8 that also displays the p.F228I mutation in WNT10A in the homozygous state.

To extend the WES analysis, we focused on families 5, 8 and 9, as genomic DNA was available from all the members with the exception of the unaffected father (I-1) of family 9. For family 5, an autosomal recessive form of inheritance seemed most probable. Our analysis identified the PITX2, TTN and MUC16 genes as affected by candidate mutations. The TTN and MUC16 genes were not considered good candidate genes for agenesis prediction, given their high RVIS score, confirming the propensity of these genes to accumulate rare functional mutations with neutral effect ([@b30-ijmm-38-05-1338]). Of note, we found a homozygous c.-387delC/G variation in the 5′UTR of the PITX2 gene in the siblings that could be associated with tooth agenesis as we mentioned above. PITX2 is a transcription factor that initiates tooth development, activating amelogenin expression, whose protein product is necessary for enamel formation. Since the mutation is localized in the promoter region of the gene, it may affect its transcriptional activity ([@b31-ijmm-38-05-1338]). A more in depth analysis of genetic variants in this family also identified an interesting variant in the BMP4 gene, a non-synonymous SNP in the homozygous state (rs17563; c.T455C:p.V152A) in the affected siblings II-1 and II-2. In a Brazilian study conducted on 46 individuals with tooth agenesis and 88 control cases, the CC genotype of BMP4 was more frequent in individuals with 3 or more missing teeth than in the control group (p\<0.0001), leading the authors to the conclusion that this variant was associated with tooth agenesis ([@b32-ijmm-38-05-1338]). The same SNP was previously found in two Mexican families with oligodontia ([@b33-ijmm-38-05-1338]). Capasso *et al* ([@b34-ijmm-38-05-1338]) observed that the c455T\>C substitution altered the BMP4 mRNA secondary structure and that the BMP4 mRNA and protein expression levels were higher for the T allele in a population in southern Italy with cutaneous melanoma. PAX9 and MSX1 synergistically activate BMP4, and BMP4 is a gene crucial to tooth development as it regulates the passage from bud to cap stages. Since the unaffected parents displayed the same genetic variations of PITX2 and BMP4 in the homozygous state, it was deemed that these variations alone were unlikely to be the direct cause of the observed tooth hypodontia; however, they may still play a role as risk factors or modulators of the phenotype.

Family 8 (a trio with unaffected parents) displayed a probable autosomic recessive form of inheritance. Unfortunately, we were unable to identify a strong candidate gene with a clear role in the physiopathology of tooth formation and development. Based on RVIS score prioritization criteria, 6 genes emerged affected by functional mutation in this family and not expected to accumulate functional mutation by chance, namely PRR32, PLAC4, nuclear factor 1A (NFIA), tripartite motif containing 14 (TRIM14), carbohydrate sulfotransferase 8 (CHST8) and synaptic Ras GTPase activating protein 1 (SYNGAP1). Of these, 3 genes were unlikely to be involved in tooth agenesis: PLAC4 is mainly involved in placenta tissue formation ([@b35-ijmm-38-05-1338]); CHST8 has been associated with autosomal recessive peeling skin syndrome ([@b36-ijmm-38-05-1338]); SYNGAP1 is responsible for non-syndromic mental retardation autosomal dominant form 5 (OMIM 612621) ([@b37-ijmm-38-05-1338]), a phenotype not reported in this family. The PRR32 gene is poorly characterized and difficult to evaluate. NFIA and TRIM14 are two transcription factor genes and they may represent good candidates for further studies aimed at assessing their involvement in the regulatory network driving teeth morphogenesis. NFIA may be of particular interest, since mutations in this gene cause craniofacial abnormalities in mice and craniosynostosis in humans ([@b38-ijmm-38-05-1338]). However, homozygous null mutations in the gene have been associated with kidney, nervous and fertility phenotypes that were not observed in this family. Of note, this family was also a carrier of the genetic variant c.387delC/G in the 5′UTR of PITX2 (found in the homozygous state in the proband and in his unaffected brother and in the heterozygous state in their unaffected mother in family 5; discussed above), suggesting that a complex interplay of genetic risk factors may be involved in this disease.

Finally, family 9 included a pair of monozygotic twins with hypodontia and the recessive inheritance model was likely. Unfortunately, DNA for the father was not available for the study. Among the genetic variants found, only the one in COMMD7 may have a link with the disease. COMMD7 is in fact a NEMO interacting protein involved in the termination of NF-κB signaling that is activated by the EDA-EDAR-EDARADD complex ([@b39-ijmm-38-05-1338]). This mutation is predicted to be damaging with a score of 1 by PolyPhen-2. Further studies are necessary to establish whether this heterozygous mutation in the proband twin may be involved in the pathological phenotype.

In conclusion, in this study, using WES analysis, we identified the causative mutations in cases with a more severe phenotype (families 1 and 7, where 17 and 16 teeth were missing, respectively). We did not immediately identify variants that may be disease-causing for families with a light phenotype, such as families 5 and 9 (maximum 4 missing teeth) and with a mild oligodontia, such as family 8 (6 missing teeth). However, our analysis of these families highlighted some interesting candidate genes that may be considered targets of future functional studies. However, we cannot exclude that the manifestation of the phenotypic traits may also depend or be modulated by other mechanisms, including long and small non-coding RNAs (i.e., miRNAs), epigenetic modifications, such as DNA methylation and histone modifications or regulatory DNA variants. Finally, since a complex regulatory network contributes to tooth formation with multitudes of genes potentially involved, we consider that WES may be an effective strategy with which to detect the genetic defects related to tooth agenesis, particularly in severe cases of oligodontia in sporadic and familial cases. The determination of the genetic causes of tooth agenesis is important for genetic counseling and for anticipating the problems related to the clinical management of dental anomalies, in order to ensure a correct occlusion, particularly during developing dentition in children.
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![Pedigrees of the 9 families in this study. Squares indicaate males, and circles indicate females. Filled symbols represent individuals diagnosed with tooth agenesis; empty symbols represent unaffected subjects. The asterisks indicate individuals for which mutational analysis for the PAX9 and MSX1 genes was performed; filled squares indicate subjects who underwent whole exome sequencing (WES) analysis; empty triangles indicate that no DNA was available. Arrows indicate the probands of each family.](IJMM-38-05-1338-g00){#f1-ijmm-38-05-1338}

![Panoramic radiograph of dentition of the proband (II-1) of family 7. The missing teeth are indicated by asterisks. Partial DNA sequences of exon 3 of WNT10A from the unaffected mother (subject I-1), the proband (II-1) and from a control subject (CTRL). The nucleotide substitution is indicated by an arrow.](IJMM-38-05-1338-g02){#f2-ijmm-38-05-1338}

![Direct sequencing analysis of mutation found by whole exome sequencing (WES) in family 1. Partial DNA sequences of exon 3 of WNT10A (left panels) and exon 7 of EDARADD (right panels) from the proband (II-1), her brother (II-2) and from a control subject. Nucleotide substitution is indicated by an arrow.](IJMM-38-05-1338-g03){#f3-ijmm-38-05-1338}

###### 

Characteristics of the probands and the affected relatives.

  Characteristic                                          N    \%
  ------------------------------------------------------- ---- ------
  Males                                                   7    44
  Females                                                 9    56
  Type of tooth agenesis (total number of cases)          16   
   Hypodontia (1--5 permanent teeth missing)              11   69
   Oligodontia (\>6 permanent teeth missing)              5    31
  Type of permanent teeth missing (total teeth missing)   81   
   Central incisor (11, 21, 31, 41)                       8    9.9
   Lateral incisor (12, 22, 32, 42)                       16   19.7
   Canine (13, 23, 33, 43)                                4    4.9
   First premolar (14, 24, 34, 44)                        9    11.1
   Second premolar (15, 25, 35, 45)                       27   33.3
   First molar (16, 26, 36, 46)                           1    1.2
   Second molar (17, 27, 37, 47)                          6    7.4
   Third molar (18, 28, 38, 48)                           10   12.3
  No. of missing incisors                                 35   43.2
  No. of missing canines                                  4    4.9
  No. of missing premolars                                25   30.8
  No. of missing molars                                   17   21

###### 

Description of oligodontia and hypodontia phenotypes.

  --
  --

Grey background indicates affected individuals subjected to whole exome sequencing (WES). Asterisks (\*) indicate missing teeth.

###### 

Summary of whole exome sequencing results.

  Sample   Family   Mean coverage in target region   \% bases covered at least 20X   No. Of exonic variants
  -------- -------- -------------------------------- ------------------------------- ------------------------
  II-1     5        100X                             93.6                            23,297
  II-1     1        171X                             95.5                            22,801
  II-1     7        77X                              91.8                            22,482
  II-1     8        82X                              92.2                            23,564
  I-1      5        75X                              83.9                            22,603
  II-2     5        82X                              85.3                            22,822
  I-2      5        82X                              85.3                            22,706
  I-1      8        83X                              85.8                            22,825
  I-2      8        80X                              84.9                            23,129
  I-2      9        82X                              91.6                            37,874
  II-2     9        100X                             92.7                            37,822
  II-3     9        88X                              91.1                            37,556

All results are reported considering the human CDS sequences as target region. Family ID are the same as those reported in [Fig. 1](#f1-ijmm-38-05-1338){ref-type="fig"}.

###### 

Selected candidate genes and variants in family 5.

  ---------------------------------------------------------------------------------------------------------------------------------------
  Gene.refGene   ExonicFunc. refGene   Chr     Ref   Alt   Func.refGene                  AAChange.refGene
  -------------- --------------------- ------- ----- ----- ----------------------------- ------------------------------------------------
  Compound                                                                               

  MUC16          Non-synonymous SNV    chr19   G     T     Exonic                        MUC16:NM_024690:exon3:c.C12953A:p.A4318D

  MUC16          Non-synonymous SNV    chr19   T     C     Exonic                        MUC16:NM_024690:exon3:c.A23897G:p.E7966G

  MUC16          Non-synonymous SNV    chr19   C     T     Exonic                        MUC16:NM_024690:exon12:c.G36581A:p.R12194Q

  TTN            Non-synonymous SNV    chr2    C     G     Exonic                        TTN:NM_003319:exon186:c.G75952C:p. E25318Q,\
                                                                                         TTN:NM_133432:exon187:c.G76327C:p.E25443Q,\
                                                                                         TTN:NM_133437:exon187:c.G76528C:p.E25510Q,\
                                                                                         TTN:NM_133378:exon307:c.G95443C:p.E31815Q,\
                                                                                         TTN:NM_001256850:exon308:c.G98224C:p.E32742Q,\
                                                                                         TTN:NM_001267550:exon358:c.G103147C:p.E34383Q

  TTN            Non-synonymous SNV    chr2    C     T     Exonic                        TTN:NM_003319:exon73:c.G18133A:p. D6045N,\
                                                                                         TTN:NM_133432:exon74:c.G18508A:p.D6170N,\
                                                                                         TTN:NM_133437:exon74:c.G18709A:p.D6237N,\
                                                                                         TTN:NM_133378:exon194:c.G37624A:p.D12542N,\
                                                                                         TTN:NM_001256850:exon195:c.G40405A:p.D13469N,\
                                                                                         TTN:NM_001267550:exon245:c.G45328A:p.D15110N

  TTN            Non-synonymous SNV    chr2    T     C     Exonic                        TTN:NM_133378:exon90:c.A23131G:p.I7711V,\
                                                                                         TTN:NM_001256850:exon91:c.A25912G:p.I8638V,\
                                                                                         TTN:NM_001267550:exon93:c.A26863G:p.I8955V

  TTN            Non-synonymous SNV    chr2    G     A     Exonic                        TTN:NM_133378:exon77:c.C19445T:p.S6482L,\
                                                                                         TTN:NM_001256850:exon78:c.C22226T:p.S7409L,\
                                                                                         TTN:NM_001267550:exon80:c.C23177T:p.S7726L

  Known                                                                                  

  PITX2          UTR5                  chr4    C     --    NM_000325: c.-387delG         

  BMP4           Exonic                chr14   T     C     NM_001202: c.T455C: p.V152A   
  ---------------------------------------------------------------------------------------------------------------------------------------

###### 

Selected candidate genes and variants in family 8.

  -------------------------------------------------------------------------------------------------------------------------
  Chr         Ref     Alt     Func.refGene   Gene.refGene   GeneDetail.refGene                   ExonicFunc.refGene
  ----------- ------- ------- -------------- -------------- ------------------------------------ --------------------------
  Recessive                                                                                      

  chrX        G       A       Exonic         ARSH           NA                                   Non-synonymous SNV

  chrX        G       A       Exonic         PRR32          NA                                   Non-synonymous SNV

  chr3        C       T       Exonic         TGM4           NA                                   Stopgain

  chr21       --      40 bp   Exonic         PLAC4          NA                                   Frameshift insertion

  chrX        G       A       Exonic         APEX2          NA                                   Non-synonymous SNV

  *De novo*                                                                                      

  chr17       21 bp   --      Splicing       MYO19          NA                                   NA

  chr16       T       G       Exonic         IFT140         NA                                   Non-synonymous SNV

  chr1        A       C       Splicing       NFIA           NM_001145511:exon9:c.12312A\>C,\     NA
                                                            NM_001145512:exon10:c.1390-2A\>C,\   
                                                            NM_005595:exon9:c.12552A\>C,\        
                                                            NM_001134673:exon9:c.1255-2A\>C      

  chr11       --      T       Exonic         MUC6           NA                                   Frameshift insertion

  chr6        G       A       Exonic         GPANK1         NA                                   Non-synonymous SNV

  chr1        G       C       Splicing       NFIA           NM_001145511:exon9:c.1231-1G\>C,\    NA
                                                            NM_001145512:exon10:c.1390-1G\>C,\   
                                                            NM_005595:exon9:c.12551G\>C,\        
                                                            NM_001134673:exon9:c.1255-1G\>C      

  chr6        A       G       Exonic         HSPA1L         NA                                   Non-synonymous SNV

  chr11       G       A       Exonic         MUC6           NA                                   Non-synonymous SNV

  chr19       --      18 bp   Exonic         RSPH6A         NA                                   Non-frameshift insertion

  chr9        C       G       Exonic         TRIM14         NA                                   Non-synonymous SNV

  chr19       --      AGC     Exonic         CHST8          NA                                   Non-frameshift insertion

  chr6        CACC\   --      Exonic         SYNGAP1        NA                                   Non-frameshift insertion
              ACCA\                                                                              
              CCAT                                                                               

  chrX        C       T       Exonic         RBMX           NA                                   Non-synonymous SNV

  chr11       G       T       Exonic         MUC6           NA                                   Non-synonymous SNV

  chr11       A       G       Exonic         MUC6           NA                                   Non-synonymous SNV

  chr11       G       --      Exonic         MUC6           NA                                   Frameshift deletion

  chr1        G       --      Splicing       SEC22B         NM_004892:exon6:c.1066-1G\>-         NA

  chr3        C       G       Exonic         IL17RE         NA                                   Non-synonymous SNV

  Compound                                                                                       

  chr2        --      CTGC    Exonic         DNAH7          NA                                   Frameshift insertion

  chr2        A       G       Exonic         DNAH7          NA                                   Non-synonymous SNV

  chr2        C       T       Exonic         DNAH7          NA                                   Non-synonymous SNV

  chr11       --      T       Exonic         MUC6           NA                                   Frameshift insertion

  chr11       G       A       Exonic         MUC6           NA                                   Non-synonymous SNV

  chr11       --      TA      Exonic         MUC6           NA                                   Frameshift insertion

  chr11       G       T       Exonic         MUC6           NA                                   Non-synonymous SNV

  chr11       A       G       Exonic         MUC6           NA                                   Non-synonymous SNV

  chr11       G       --      Exonic         MUC6           NA                                   Frameshift deletion

  chr1        A       C       Splicing       NFIA           NM_001145511:exon9:c.1231-2A\>C,\    NA
                                                            NM_001145512:exon10:c.1390-2A\>C,\   
                                                            NM_005595:exon9:c.1255-2A\>C,\       
                                                            NM_001134673:exon9:c.1255-2A\>C      

  chr1        G       C       Splicing       NFIA           NM_001145511:exon9:c.1231-1G\>C,\    NA
                                                            NM_001145512:exon10:c.1390-1G\>C,\   
                                                            NM_005595:exon9:c.1255-1G\>C,\       
                                                            NM_001134673:exon9:c.1255-1G\>C      

  chr10       A       T       Splicing       NRAP           NM_006175:exon38:c.4431+2T\>A,\      NA
                                                            NM_198060:exon39:c.4536+2T\>A,\      
                                                            NM_001261463:exon39:c.4536+2T\>A     

  chr10       T       G       Exonic         NRAP           NA                                   Nonsynonymous SNV

  Known                                                                                          

  PITX2       UTR5    chr4    C              --             NM_000325:c.-387delG                 
  -------------------------------------------------------------------------------------------------------------------------

###### 

Selected candidate genes and variants in family 9.

  ---------------------------------------------------------------------------------------------------------------------------------------------------
  Chr         Ref   Alt   Func. refGene   Gene. refGene   GeneDetail. refGene   ExonicFunc. refGene   AAChange.refGene
  ----------- ----- ----- --------------- --------------- --------------------- --------------------- -----------------------------------------------
  Compound                                                                                            

  chr20       A     G     Exonic          ANKEF1          NA                    Non-synonymous SNV    ANKEF1:NM_198798:exon2:c.A332G:p.D111G,\
                                                                                                      ANKEF1:NM_022096:exon3:c.A332G:p.D111G

  chr20       C     T     Exonic          COMMD7          NA                    Non-synonymous SNV    COMMD7:NM_001099339:exon1:c.G5A:p.G2D,\
                                                                                                      COMMD7:NM_053041:exon1:c.G5A:p.G2D

  chr14       T     C     Exonic          DDHD1           NA                    Non-synonymous SNV    DDHD1:NM_001160148:exon6:c.A1411G:p.I471V,\
                                                                                                      DDHD1:NM_030637:exon6:c.A1411G:p.I471V,\
                                                                                                      DDHD1:NM_001160147:exon7:c.A1432G:p.I478V

  chr8        A     G     Exonic          EBF2            NA                    Non-synonymous SNV    EBF2:NM_022659:exon7:c.T560C:p.L187S

  chr17       G     T     Exonic          EVPL            NA                    Non-synonymous SNV    EVPL:NM_001988:exon11:c.C1213A:p.L405M

  chr3        C     T     Exonic          SUCLG2          NA                    Non-synonymous SNV    SUCLG2:NM_001177599:exon10:c.G1124A:p.G375E,\
                                                                                                      SUCLG2:NM_003848:exon10:c.G1124A:p.G375E

  chr3        C     T     Exonic          SUCLG2          NA                    Non-synonymous SNV    SUCLG2:NM_001177599:exon10:c.G1123A:p.G375R,\
                                                                                                      SUCLG2:NM_003848:exon10:c.G1123A:p.G375R

  chr17       T     C     Exonic          SUPT6H          NA                    Non-synonymous SNV    SUPT6H:NM_003170:exon32:c.T4393C:p.C1465R

  *De novo*                                                                                           

  chr3        C     T     Exonic          SUCLG2          NA                    Non-synonymous SNV    SUCLG2:NM_001177599:exon10:c.G1124A:p.G375E,\
                                                                                                      SUCLG2:NM_003848:exon10:c.G1124A:p.G375E

  chr3        C     T     Exonic          SUCLG2          NA                    Non-synonymous SNV    SUCLG2:NM_001177599:exon10:c.G1123A:p.G375R,\
                                                                                                      SUCLG2:NM_003848:exon10:c.G1123A:p.G375R
  ---------------------------------------------------------------------------------------------------------------------------------------------------
